A

Albuquerque Neuroscience | Albuquerque, NM

Research site

(Unclaimed)

Location

101 Hospital Loop NE, Suite 209, Albuquerque, New Mexico, United States of America

Site insights

Top conditions

Top treatments

Rapastinel

Simufilam

Duloxetine

Galcanezumab

Lemborexant

Pregabalin

Zolpidem

Solanezumab

Capsaicin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 12 total trials

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

This is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and sa...

Enrolling

Post Surgical Neuropathic Pain

Drug: capsaicin 0.04% topical system

Drug: Qutenza (capsaicin) 8% topical system

Open-label Extension for Phase 3 Clinical Trials of Simufilam

The goal of this open-label extension study is to assess long-term safety and tolerability of simufilam 100 mg in subjects who have completed the RET...

Invitation-only

Alzheimer Disease

Drug: Simufilam

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease (RETHINK-ALZ)

A 52-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 52 we...

Active, not recruiting

Alzheimer Disease

Drug: Placebo

Drug: Simufilam